Stonepine Capital Management LLC Sells 93,409 Shares of Aytu BioPharma, Inc. (NASDAQ:AYTU)

Stonepine Capital Management LLC reduced its holdings in Aytu BioPharma, Inc. (NASDAQ:AYTU) by 18.6% in the 4th quarter, Holdings Channel reports. The fund owned 407,549 shares of the company’s stock after selling 93,409 shares during the quarter. Stonepine Capital Management LLC owned 0.07% of Aytu BioPharma worth $693,000 at the end of the most recent quarter.

Aytu BioPharma Stock Down 17.8%

Shares of Aytu BioPharma stock opened at $2.13 on Friday. Aytu BioPharma, Inc. has a 1 year low of $0.95 and a 1 year high of $3.24. The business has a 50-day moving average of $1.20 and a two-hundred day moving average of $1.44. The company has a market capitalization of $13.14 million, a P/E ratio of -1.47 and a beta of -0.10. The company has a debt-to-equity ratio of 0.32, a current ratio of 0.98 and a quick ratio of 0.81.

Aytu BioPharma (NASDAQ:AYTU) last posted its quarterly earnings data on Wednesday, May 14th. The company reported $0.20 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.17) by $0.37. The business had revenue of $18.45 million during the quarter, compared to the consensus estimate of $13.74 million. Aytu BioPharma had a negative return on equity of 19.30% and a negative net margin of 7.62%.

About Aytu BioPharma

Aytu Biopharma, Inc is a specialty pharmaceutical company, which engages in identifying, acquiring, and commercializing novel products. It operates through the Rx and Consumer Health segments. The RX segment consists of various prescription pharmaceutical products sold through third parties. The Consumer Health segment includes various consumer health products sold directly to consumers.